Miyako Capital — Full Portfolio
46 tracked investments · listed companies and verified rows first
BizteX provides RPA (robotic process automation) and no-code data integration tools to eliminate manual administrative work and connect systems and SaaS platforms.
AI & Machine LearningDeveloper ToolsEnterprise SoftwareFuture of WorkSaaSTokyo, JP
嶋田 光敏(Founder/CEO)
Co-investorsWiLKDDI Open Innovation FundGenesia Ventures
Galdieria is a microalga species that produces a precious metal adsorbent material derived from its dried cells, designed for metal recovery in recycling and artisanal gold mining operations.
BiotechCircular EconomyCleantechClimate TechNew MaterialsTokyo, JP
Tanimoto(Representative)谷本 肇(Representative Director CEO)
LINK-US Co., Ltd. develops, designs, and manufactures devices based on ultrasonic complex vibration and high-power ultrasonic technology, including room-temperature bonding equipment for joining same and dissimilar metal materials.
Advanced ManufacturingDeep TechHardwareTokyo, JP
Jun Mitsuyuki(Representative Director)
Co-investorsShizuoka CapitalKepple GroupMitsubishi UFJ CapitalMizuho CapitalSMBC Venture CapitalSumitomo Mitsui Trust nvestment Co. Ltd.
Megakaryon is a regenerative medicine company that develops cell therapies, including iPS cell-derived products such as platelets, for clinical applications.
BiotechHealthtechLongevityMedical DevicesKyoto, JP
Co-investorsDBJ CapitalJapan Asia InvestmentKSP, Inc.Mitsubishi UFJ CapitalMizuho CapitalNissay Capital+1 more
Peds3 develops digital and evidence-based care solutions for pediatric and maternal-child health, serving healthcare providers and families through treatment applications and medical programs.
AI & Machine LearningDigital HealthHealthtechMedical DevicesTokyo, JP
Board千先園子
RegiMMune is a biotech company with an investor relations section providing financial reports and corporate governance documents.
BiotechDigital HealthMedical DevicesTaiwan, TW
Steve Yang(Chief Executive Officer)Reiko Namikawa(Executive Vice President, Clinical Development)
BoardKenzo Kosuda(Chairman; Member of the Board of Directors)
Co-investorsDBJ CapitalHiroshima Venture Capital Co. Ltd.Oita Venture Capital
PR TIMES is a press release distribution service that helps companies distribute news releases to media and the public, with content syndicated across more than 260 partner sites.
Marketing TechMedia & EntertainmentSaaS
Co-investorsAngel Bridge Co.,Ltd.basepartnersDD Holdings Venture CapitalDIMENSIONi Cubed Venturesi-nest capital+7 more
Aigo develops an Integrated Neuro-Symbolic Architecture (INSA) that combines symbolic reasoning with neural networks to pursue artificial general intelligence (AGI), positioning this as a more power-efficient alternative to large language models.
AI & Machine LearningDeep TechEnterprise Software
Peter Voss
Algo Artis provides technology solutions to optimize social infrastructure by combining advanced technical expertise with deep understanding of on-site constraints.
Advanced ManufacturingAI & Machine LearningDeep TechEnergyEnterprise SoftwareTokyo, JP
Board永田 健太郎
Co-investorsDIMENSIONK4 VenturesSalesforce VenturesDRONE FUNDSony Ventures CorporationUTEC
Drivemode builds vehicle companion apps and in-vehicle software platforms for Honda and Acura cars and electric motorcycles, including connected apps like Honda RoadSync and the Drivemode Android app.
IoTMobility & TransportationSaaSSan Jose, US
Yokichi Koga(Executive Officer, Director)Yo Koga(CEO)in
Co-investorsHonda Innovations Silicon Valley
EX-Fusion is a Japanese private company developing laser-based nuclear fusion energy technology, aiming to decarbonize existing energy sources and contribute to carbon neutrality.
CleantechDeep TechEnergyKyoto, JP
Kazuki Matsuo(代表取締役社長 (President & CEO))
Co-investorsDelight VenturesMPowerOSAKA University Venture CapitalShizuoka Capital
Floadia develops and licenses non-volatile embedded memory IP, including manufacturing process technology and circuit designs, to semiconductor makers and foundries.
AI & Machine LearningDeep TechHardwareSemiconductorsKodaira, JP
Kosuke Okuyama(President & CEO)
Co-investorsTEL Venture Capital, Inc.UMC CapitalUntroD Capital
Goryo Chemical develops fluorescence-based technology to visualize diseases and support diagnosis and treatment.
BiotechHealthtechMedical DevicesNew MaterialsTokyo, JP
Co-investorsDG IncubationS VenturesUniversal Materials Incubator
Hephas Energy develops environmentally friendly technologies and digital transformation tools aimed at supporting smart city initiatives and sustainable development.
CleantechClimate TechEnergy
A Japanese company that develops and provides evaluation platforms for schools and enterprises to quantify human abilities and characteristics, including non-cognitive skills.
AI & Machine LearningEdTechHR TechTokyo, JP
福原 正大(Representative Director, Chairman & CEO)中里 忍(Representative Director & COO)
A biotechnology company, founded in 2013, developing regenerative medicine technologies including methods to differentiate stem cells into cardiovascular cells and hydrogel-particle-based layering techniques.
BiotechDeep TechLongevityMedical Devices
Co-investorsUntroD Capital
Liqid provides composable infrastructure software and hardware that lets datacenters disaggregate servers and dynamically allocate accelerators such as GPUs across resources to match specific workloads.
Cloud ComputingData & InfrastructureEnterprise SoftwareHardwareWestminster, US
Jason Breakstone(Executive Officer, Director)Sumit Puri(Founder)inJim Antes(Executive Officer)Bryan Schramm(Executive Officer)inEdgar Masri(Executive Officer, Director)in
BoardRyan Pollock(Director)in
Co-investorsChartline Capital Partners
LocationMind provides location intelligence and spatial analysis services using GNSS positioning, satellite imagery, IoT sensing (LiDAR, UWB), and mobile big data to support urban planning, infrastructure, mobility, and commercial applications across multiple sectors.
AI & Machine LearningData & InfrastructureIoTTokyo, JP
Naoki Kiritani(Founder / CEO)Ryosuke Shibasaki(Founder / CTO)Dinesh Manandhar(Founder / CDO)
Co-investorsFunds StartupsHulic StartupShizuoka CapitalZENRIN FUTURE PARTNERS
mui Lab designs and manufactures calm technology interfaces and IoT systems that integrate natural materials with digital touchpoints for smart home and wellness applications.
ConsumerHardwareIoTSaaSKyoto-shi, JP
Kazunori Oki(Co-founder & CEO)in
Co-investorsMonozukuri VenturesTechstars
Oishii operates indoor vertical farms that grow premium produce including its Omakase Berry strawberries and Rubī Tomato, sold direct to consumers and through retail partners like Whole Foods.
AgTechDirect to ConsumerFoodTech
Hiroki Koga(Co-founder)inBrendan Somerville(Co-founder)
Co-investorsBloom8Grit VenturesMcWin Capital PartnersMobile Internet Capital, Inc.Sony Ventures Corporation
Orange develops a batch localization tool for manga and is building emaqi, a manga e-bookstore service planned to launch in the US in 2024.
AI & Machine LearningConsumerMedia & Entertainment
Co-investorsGlobis Capital Partners
Pentalink develops a fully automated sericulture system to produce silk fiber as a sustainable natural alternative to petroleum-based synthetic textiles.
AgTechBiotechNew MaterialsRobotics京都市, JP
Board野中 明
Sakana AI develops frontier AI research and products, including large language models, multi-agent orchestration systems, and AI solutions tailored for Japanese enterprises and public sector organizations.
AI & Machine LearningCloud ComputingDeep TechDefense TechTokyo, JP
David Ha(Co-Founder & CEO)Ren Ito(Co-Founder & Chairman)inLlion Jones(Co-Founder & CTO)
Co-investorsGlobal BrainBasis Set VenturesIn-Q-Tel500 GlobalFujitsu VenturesGeodesic Capital+11 more
SFG Sciences is a drug discovery and development company focused on creating breakthrough therapeutics across various diseases.
Biotech
Board上村 尚人エイミー・ブロイドリック
Co-investorsVision Incubate
SocialGood offers a shopping cash-back service and browser extension covering over 20,000 stores, where users earn rewards in the platform's SG cryptocurrency.
ConsumerCrypto & Web3E-commerce
Japanese company that plans, develops, and sells IT products.
Enterprise SoftwareSaaSTokyo, JP
高嶋 晃(代表取締役 (CEO))
Co-investorsMonozukuri Ventures
UltraSolar Technology develops QuantumBoost (QB), a hardware device that increases the power output of photovoltaic modules by over 10% and lowers the levelized cost of energy for solar farm owners and operators.
CleantechEnergyHardwareSanta Clara, US
Santosh Kumar(Executive Officer, Director)Rob Soni(Director)Rahul Chopra(Director)
BoardYsunesaburo Sugaya(Director)
Varinos develops and provides genetic testing services applying genome technology, including a uterine microbiome (endometrial flora) test used in fertility and reproductive medicine.
BiotechDigital HealthFemTechMedical DevicesTokyo, JP
桜庭 喜行(Founder & Chairman (former CEO))長井 陽子(Co-founder)Sakuraba(CEO)Yoshiyuki Sakuraba(Founder)inYoko Nagai(Founder)in齊藤 洋一(代表取締役CEO)
Co-investorsAngel Bridge Co.,Ltd.Fast Track InitiativeMIRAI SOUZOUSony Ventures Corporation
Viage Therapeutics is a neuroscience drug developer working on novel oral neurotherapeutics that target the gut-brain axis, including its lead clinical candidate DGX-001 for cognitive impairment in conditions such as Alzheimer's and Parkinson's disease.
BiotechDeep TechHealthtechSan Francisco Bay Area, US
Titus Plattel(Leadership Team)inBrian Rogers(Leadership Team)inNeil Schwartz(Leadership Team)inSujata Sankar(Leadership Team)inSteven King(Leadership Team)in
Co-investorsKyoto University Innovation CapitalRDiscoveryRemiges Ventures, Inc.
Vivid develops hardware development kits and display technologies for augmented and virtual reality headsets, with applications in automotive heads-up displays and holographic displays.
Deep TechGamingHardwareCambridge, GB
Aleksandra Pedraszewska(Co-founder)inTom Durrant(Co-founder)in
Co-investorsUTokyo Innovation Platform Co. Ltd.
Startbahn provides blockchain-based platforms for creators and artists to authenticate digital and physical artworks, manage collectible provenance, and capture resale royalties.
Creator EconomyCrypto & Web3Marketing TechMedia & EntertainmentSaaSTokyo, JP
Co-investorsSX Capital, Inc.TBS Innovation Partners
Co-investorsAngel Bridge Co.,Ltd.Beyond Next VenturesUniversal Materials Incubator
Sukutachi is a mobile app that connects construction businesses and craftspeople to discover work opportunities and expand their professional networks.
Construction TechMarketplaces
Co-investorsANOBAKAJapan Post Capital Co. Ltd.MPowerGenesia Ventures
Innovative Space Carrier (将来宇宙輸送システム株式会社) is a Japanese company developing future space transportation systems.
Deep TechHardwareLogistics & Supply ChainSpace TechTokyo, JP
畑田 (Hatakuta)(CEO)畑田 康二郎(代表取締役社長 兼 最高経営責任者 (CEO))野村 (Nomura)(COO)
Co-investorsAngel Bridge Co.,Ltd.Dentsu VenturesXTech Ventures
Co-investorsShizuoka CapitalX-HUB TOKYO Global Startup AcceleratorEnergy & Environment Investment
FLOSFIA develops power semiconductor devices based on corundum-structure gallium oxide (α-Ga₂O₃), a material originating from Kyoto University in Japan, using its proprietary water-based "MISTEPITAXY" mist deposition process to achieve lower loss than SiC at silicon-level cost.
CleantechDeep TechNew MaterialsSemiconductorsKyoto, JP
人羅俊実(創業者・取締役会長 (Founder & Chairman))四戸孝(代表取締役社長 (President & CEO))
Co-investorsKyoto University Innovation CapitalUTECEnergy & Environment Investment
Liberaware develops compact inspection drones and data editing and analysis technology to inspect narrow, dark, and hazardous indoor spaces.
Deep TechHardwareIoTRoboticsTokyo, JP
Co-investorsJR East Start UPBonds Investment GroupDRONE FUND
Ai-BrainScience Inc. is a Japanese company holding a Type 2 medical device manufacturing and sales license.
AI & Machine LearningDigital HealthHealthtechMedical DevicesSuita, JP
森下 竜一(取締役会長 (Chairman))髙村 健太郎(代表取締役社長 (President & CEO))
Board北嶋 学(取締役 (Director))
Co-investorsNippon Venture CapitalOSAKA University Venture Capital
StemRIM is a biopharmaceutical company developing regenerative medicine therapies.
BiotechHealthtechMedical Devices
Co-investorsNippon Venture CapitalSMBC Venture Capital
Kyoto Drug develops novel therapeutic drugs for rare and difficult-to-treat ocular diseases including retinal artery occlusion and retinitis pigmentosa, using a new small-molecule compound (KUS agent) based on research from Kyoto University.
BiotechMedical DevicesKyoto, JP
Musashi (武蔵)(CEO)
Co-investorsKyoto University Innovation Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.


